Evaluation of the efficacy of MMX mesalazine therapy for moderate ulcerative colitis
Introduction. Treatment of patients with ulcerative colitis (UC) requires continuous anti-relapse therapy. Mesalazines are the firstline disease-modifying drugs for the treatment of mild to moderate UC to manage exacerbations and to induce and maintain remission.This paper is aimed at comparing the...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Artigo |
| Sprache: | Russo |
| Veröffentlicht: |
Remedium Group LLC
2021-05-01
|
| Schriftenreihe: | Медицинский совет |
| Schlagworte: | |
| Online-Zugang: | https://www.med-sovet.pro/jour/article/view/6177 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|